Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Fox Corp Class B (FOX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Fox Corp Class B — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.03 (market cap $4.59B), while Fox Corp Class B trades at $55.42 (market cap $25.36B). The key difference: Fox Corp Class B is far larger — about 5.5× Definium Therapeutics Inc. Common Shares's market cap, and Fox Corp Class B pays a 1.02% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Fox Corp Class B for 75 Days on average.
| DFTX | FOX | |
|---|---|---|
Market Cap | $4.59B | $25.36B |
Volume | 2,103,937 | 886,620 |
Sector | Health | Media |
52-Week High | $48.45 | $67.76 |
52-Week Low | $10.68 | $44.39 |
Typical Hold Time | 0 Days | 75 Days |
Enterprise Value | $3.55B | $28.72B |
Dividend Yield | — | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FOX trades at $56.13, up 0.27% today, with a bullish technical signal from moving averages and a consensus analyst price target of $84.75 implying significant upside. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.79 surpassing the $1.44 estimate. Fundamentals show robust growth, with 2025 revenue reaching $16.30 billion and net income margin improving to 13.88%.
The outlook is positive given valuation multiples below industry averages and consistent earnings outperformance, but risks include a projected net cash flow decline in 2026 and competitive pressures in the media sector. Investor sentiment is mixed, with analyst ratings nearly evenly split between Buy and Hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Fox Corp Class B
Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.
Read more on FOX →
